UBS Maintains Neutral on Medtronic, Lowers Price Target to $90

Benzinga Newsdesk www.benzinga.com Negative 74.3%

Neg 74.3% Neu 0% Pos 0%

UBS analyst Priya Sachdeva maintains Medtronic (NYSE:MDT) with a Neutral and lowers the price target from $104 to $90.

Comments

No comments yet. Be the first!